Jessica Stark

Jessica Stark is a researcher at Memorial Sloan Kettering Cancer Center, focusing on glycobiology, cancer immunology, and synthetic biology. She holds a Ph.D. in Chemical Engineering from Northwestern University (2019) and a B.S. from Cornell University (2012). Her work explores glyco-immune checkpoints, cell-free biosynthesis platforms, and vaccine development.

Her research interests include Siglec receptor biology, immunotherapy, and biotechnology. Notable achievements include developing antibody-lectin chimeras for immune checkpoint blockade and rapid glycoprotein synthesis using freeze-dried cell lysates.

Awards include the Burroughs Wellcome Fund Career Award (2023–2028), MERIT Emerging Leader at Sloan Kettering Institute (2022), and recognition from the American Chemical Society (2022). Her work spans cancer immunology, SARS-CoV-2 host factors, and educational tools like BioBits kits.